Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACHE | P22303 | 3/20 | 0.31 |
| ▸ | CA1 | P00915 | 3/20 | 0.31 |
| ▸ | CA2 | P00918 | 3/20 | 0.31 |
| ▸ | HTR2A | P28223 | 1/20 | 0.31 |
| ▸ | HTR2C | P28335 | 1/20 | 0.31 |
| ▸ | HTR6 | P50406 | 1/20 | 0.31 |
| ▸ | MAOA | P21397 | 2/20 | 0.30 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.30 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.30 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.30 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.30 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.30 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.30 |
| ▸ | NOS2 | P35228 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9881115 | 0.80 | ACHE (0.46) | ACHEHTR2AHTR2CMAOACYP1A2 | |
| SCHEMBL6651167 | 0.73 | SMN1; SMN2 (0.40) | CA1CA2MAOAKDM4EALOX15 | |
| SCHEMBL12957802 | 0.71 | ACHE (0.32) | ACHECA1CA2HTR2AHTR2C | |
| SCHEMBL27271283 | 0.65 | HTR2A (0.33) | ACHEHTR2AHTR2CHTR6MAOA | |
| SCHEMBL8572018 | 0.65 | CA1 (0.57) | CA1CA2HTR2AHTR2CHTR6 | |
| SCHEMBL257566 | 0.64 | GPR3 (0.52) | HTR6CYP1A2CYP2D6KDM4EMAPK1 | |
| SCHEMBL24611521 | 0.63 | GPR3 (0.31) | HTR2AHTR2CMAOACYP1A2CYP2D6 | |
| SCHEMBL21538077 | 0.63 | CA1 (0.58) | CA1CA2HTR2AHTR2CHTR6 | |
| SCHEMBL20468978 | 0.63 | CA1 (0.58) | CA1CA2HTR2AHTR2CHTR6 | |
| SCHEMBL14432952 | 0.60 | HTR6 (0.56) | HTR2AHTR2CHTR6KDM4EALOX15 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200321533-A1 | COMPOUNDS FOR ORGANIC LIGHT EMITTING DIODE MATERIALS | THE SCRIPPS RESEARCH INSTITUTE | 2020-10-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200321533-A1 | COMPOUNDS FOR ORGANIC LIGHT EMITTING DIODE MATERIALS | ALDH1A2, DDT, CLTB | ACHE 914/4885CA1 3881/4885CA2 4674/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.